MedPath

Effect of diaphragmatic breathing exercise on heart rate and blood pressure

Phase 3
Conditions
Hypertension.
Essential (primary) hypertension
RO3.0
Registration Number
IRCT20201024049129N1
Lead Sponsor
Riphah International university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Patients with age range 45-65 years
Patients clinically diagnosed with hypertension
Patients who will give consent to abide by treatment for 4 weeks.

Exclusion Criteria

History of precious surgery
History of rib fracture
Any neurological problem
Patients with respiratory disease
Patients with coronary artery disease
Pregnant females

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic and Diastolic Blood Pressure. Timepoint: Pre Intervention and Post Intervention for all 4 weeks. Method of measurement: Mercury Spygmomanometer.
Secondary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: Pre intervention and post intervention at the end of each day for 4 weeks. Method of measurement: By pulse oximeter in minutes.
© Copyright 2025. All Rights Reserved by MedPath